Targeted disruption of the tumor necrosis factor-α gene: Metabolic consequences in obese and nonobese mice

Diabetes

Volumn 46, Issue 9, 1997, Pages 1526-1531

  Ventre, John ^a   Doebber, Thomas ^a   Wu, Margaret ^a   MacNaul, Karen ^a   Stevens, Karla ^a   Pasparakis, Manolis ^b   Kollias, George ^b   Moller, David E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOSE; INSULIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNOREGULATION; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 0030864185     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.9.1526     Document Type: Article

References (23)

1. Beutler B, Cerami A: Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 9:57-66, 1988
2. Spiegelman BM, Hotamisligil GS: Through thick and thin: wasting, obesity, and TNFα. Cell 73:625-627, 1993
3. Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, Moller DE: Negative regulation of peroxisome proliferator-activated receptor-γ gene expression contributes to the antiadipogenic effects of tumor necrosis factor-α. Mol Endocrinol 10:1457-1466, 1996
4. Torti FM, Dieckmann B, Beutler B, Cerami A, Ringold GM: A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 229:867-869, 1985
5. Stephens JM, Pekala PH: Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 cells by tumor necrosis factor-alpha. J Biol Chem 266:21839-21845, 1991
6. Norman RA, Bogardus C, Ravussin E: Linkage between obesity and a marker near the tumor necrosis factor-α locus in Pima Indians. J Clin Invest 96:158-162, 1995
7. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
8. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
9. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
10. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNFα by human muscle: relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
11. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A: Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058, 1993
12. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF - and obesity-induced insulin resistance. Science 271:665-668, 1996
13. Kanety H, Hemi R, Papa MZ, Karasik A: Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 271:9895-9897, 1996
14. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G: Immune and inflammatory responses in TNFα-deficient mice: a critical requirement in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397-1441, 1996
15. Young JK, McKenzie JC, Brady LS, Herkenham M: Hypothalamic lesions increase levels of neuropeptide Y mRNA in the arcuate nucleus of mice. Neurosci Lett 165:13-17, 1994
16. Salmon DMV, Flatt JP: Effect of dietary fat content on the incidence of obesity among ad libitum fed mice. Int J Obes 9:443-449, 1985
17. Sadur CN, Eckel RH: Insulin stimulation of adipose tissue lipoprotein lipase. J Clin Invest 69:1119-1125, 1982
18. Doebber TW, Wu M, Ventre J: In vitro exposure of white adipose tissue to the insulin sensitizing thiazolidinediones enhances insulin stimulation of glycogen synthesis (Abstract). Diabetes 45 (Suppl. 2):92A, 1996
19. Petruschke TH, Hauner H: Tumor necrosis factor-α prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocr Metab 76:742-747, 1993
20. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377-1379, 1996
21. Stephens JM, Lee J, Pilch PF: Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272:971-976, 1997
22. Guo D, Donner DB: Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate-1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 271:615-618, 1996
23. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996